Eric Santa's most recent trade in Myriad Genetics, Inc. was a trade of 1,769 Common Stock done at an average price of $25.9 . Disclosure was reported to the exchange on April 1, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Myriad Genetics, Inc. | Eric Santa | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.88 per share. | 01 Apr 2022 | 1,769 | 56,734 (0%) | 0% | 25.9 | 45,782 | Common Stock |
Myriad Genetics, Inc. | Eric Santa | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.88 per share. | 01 Apr 2022 | 1,207 | 58,503 (0%) | 0% | 25.9 | 31,237 | Common Stock |
Myriad Genetics, Inc. | Eric Santa | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 19,238 | 59,710 (0%) | 0% | 0 | Common Stock | |
Myriad Genetics, Inc. | Eric Santa | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 24,052 | 40,472 (0%) | 0% | 0 | Common Stock | |
Myriad Genetics, Inc. | Eric Santa | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,420 | 16,420 (0%) | 0% | 0 | Common Stock |